Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKesson
Cantor Fitzgerald
Merck
Fish and Richardson
Chubb
US Army
Healthtrust
Fuji

Generated: February 16, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021271

« Back to Dashboard

NDA 021271 describes IPRIVASK, which is a drug marketed by Valeant Pharms North and is included in one NDA. Additional details are available on the IPRIVASK profile page.

The generic ingredient in IPRIVASK is desirudin recombinant. Additional details are available on the desirudin recombinant profile page.
Summary for 021271
Tradename:IPRIVASK
Applicant:Valeant Pharms North
Ingredient:desirudin recombinant
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;SUBCUTANEOUSStrength15MG/VIAL
Approval Date:Apr 4, 2003TE:RLD:Yes

Expired US Patents for NDA 021271

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Chinese Patent Office
Federal Trade Commission
Cipla
McKinsey
Harvard Business School
Merck
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.